4.6 Article

Gradual cerebral hypoperfusion in spontaneously hypertensive rats induces slowly evolving white matter abnormalities and impairs working memory

期刊

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
卷 36, 期 9, 页码 1592-1602

出版社

NATURE PUBLISHING GROUP
DOI: 10.1177/0271678X15606717

关键词

Vascular dementia; chronic cerebral hypoperfusion; ameroid constrictor; white matter change; spontaneously hypertensive rat

资金

  1. Ministry of Health, Labour, and Welfare [0605-1]
  2. MRC [G0400074, G0502157, G1100540, G0900652] Funding Source: UKRI
  3. Alzheimers Research UK [ART-PG2010-3] Funding Source: researchfish
  4. Alzheimer's Society [152] Funding Source: researchfish
  5. Medical Research Council [G0400074, MR/K026992/1, G0900652, G1100540, G0502157] Funding Source: researchfish
  6. Grants-in-Aid for Scientific Research [15H04271, 15K09920, 26290023] Funding Source: KAKEN

向作者/读者索取更多资源

Rats subjected to bilateral common carotid arteries (CCAs) occlusion or 2-vessel occlusion (2VO) have been used as animal models of subcortical ischemic vascular dementia (SIVD). However, these models possess an inherent limitation in that cerebral blood flow (CBF) drops sharply and substantially after ligation of CCAs without vascular risk factors and causative small vessel changes. We previously reported a novel rat model of 2-vessel gradual occlusion (2VGO) in which ameroid constrictors (ACs) were placed bilaterally in the CCAs of Wistar-Kyoto rats. To simulate SIVD pathology more closely, we applied ACs in spontaneously hypertensive rats (SHRs), which naturally develop small vessel pathology, and compared their phenotypes with SHR-2VO and sham-operated rats. The mortality rate of the SHR-2VGO was 0% while that of the SHR-2VO was 56.5%. The CBF of the SHR-2VO dropped to 50% of the baseline level at 3h, whereas the SHR-2VGO showed a gradual CBF reduction reaching only 68% of the baseline level at seven days. The SHR-2VGO showed slowly evolving white matter abnormalities and subsequent spatial working memory impairments of a similar magnitude to the remaining SHR-2VO at 28 days. We suggest the SHR-2VGO robustly replicates selective aspects of the pathophysiology of SIVD with low mortality rate.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据